CTVACorteva Inc
81.50USD+3.74%Mkt Cap: 52.42B $P/E: 47.62

Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for…

HeadlineSourceTime
This week
Corteva's Stock Now Has Better Setup Into Upcoming Investor Days, Spin off, Following Earnings, UBS Says

Corteva's (CTVA) stock now has a better setup into the upcoming investor days on Sept. 15 and the sp

MMT Newswires
Corteva (CTVA) Stock May Be 32% Undervalued After Debt Exchange Offers

Corteva stock has delivered a 90.7% return over the past 5 years, yet today its valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples suggest the shares are not cheap. With the company also preparing to separate into two listed businesses, investors are weighing whether the current US$76.01 price already reflects that reshaping. A 90.7% total return over 5 years suggests Corteva has already rewarded long...

Simply Wall St.
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report

Download the Complete Report Here Cibus, Inc. (CBUS) Interoc Expands Rice Pipeline to Five Traits; Platform Revenue and Cost Discipline Advance as LATAM Launch Moves to 2028 Key Takeaways: Rice commercialization advanced as Interoc testing began and the relationship expanded from two to five traits, although initial LATAM launch timing moved to 2028. Sustainable Ingredients […] The post Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report appeared first

EExec Edge
Can Strategic Investments Boost Mission Produce's Returns?

AVO's Calavo acquisition and farming investments aim to expand scale, improve margins and support stronger returns as volumes grow.

Zacks
Older
DOLE vs. CTVA: Which Stock Is the Better Value Option?

DOLE vs. CTVA: Which Stock Is the Better Value Option?

Zacks
Corteva's Higher 2026 Guidance Puts Investor Focus on Growth Drivers

CTVA's Q2 earnings beat and raised 2026 outlook signal progress, but Crop Protection pricing and separation risks remain.

Zacks
Corteva Growth Improves, But Valuation Limits Upside

CTVA's stronger earnings outlook is supported by Seed growth and productivity gains, but Crop Protection pricing and separation risks persist.

Zacks
Can Expanding Avocado Consumption Benefit Mission Produce?

AVO is gaining from rising avocado consumption, higher volumes and expanded scale after the Calavo acquisition, supporting long-term growth.

Zacks
Are Wall Street Analysts Bullish on Corteva Stock?

Despite Corteva's underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. With a market cap of $51.3 billion, Corteva, Inc. (CTVA) is a global pure-play agriculture company providing innovative seed, crop protection, and digital solutions to address the world’s most pressing agricultural challenges. Through its strong brands, advanced technology pipeline, and customer-focused approach, the company

Barchart
Corteva (CTVA) Q2 2026 Earnings Call Transcript

Seed demand and crop protection growth drive upward guidance revision.

Motley Fool
Will the Calavo Deal Transform Mission Produce's Growth Path?

AVO's Calavo deal adds packing capacity, prepared foods and $25M in synergies, opening new paths for profitable long-term growth.

Zacks
Corteva Inc (CTVA) (Q2 2026) Earnings Call Highlights: Strong First-Half Performance and Raised ...

Corteva Inc (CTVA) raises full-year 2026 outlook on robust seed growth and innovation, while navigating pricing pressures and separation costs.

GuruFocus.com
Fertilizer, Fuel Price Spikes Sting South American Farmers

America’s largest agriculture companies are warning that spiking fuel and fertilizer costs due to the war in Iran are hampering South American farmers' crop-planting plans. Executives at grain giant Bunge and seed-and-pesticide seller Corteva this week said rising costs and limited access to credit is expected to flatline production of Brazil's second-corn crop. The crop, known as safrinha, represents about 80% of Brazil’s total corn production, which historically has grown at roughly 6% annually, according to analysts.

The Wall Street Journal
Corteva (CTVA) Lifts 2026 Outlook As Split Plans Stay On Track

Corteva (NYSE:CTVA) reported strong first half 2026 results. The company raised its full year 2026 outlook based on current business performance. Corteva confirmed it is on track for a planned corporate separation on October 1, 2026. The separation is expected to create two focused, industry leading businesses. Corteva operates at the intersection of seeds, crop protection and agricultural technologies, so its latest update matters for anyone watching global food production and input...

Simply Wall St.
Corteva Q2 Earnings Call Highlights

Corteva (NYSE:CTVA) raised its full-year outlook after reporting higher first-half sales, earnings and margins, citing demand for its seed technologies, growth in new crop-protection products, licensing income and cost discipline. The agricultural company also said it remains on schedule to separate

MarketBeat
Are You Looking for a Top Momentum Pick? Why Corteva, Inc. (CTVA) is a Great Choice

Does Corteva, Inc. (CTVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks
Corteva Q2 Earnings Beat Estimates, Sales Miss, '26 Outlook Raised

CTVA's Q2 EPS beats estimates as Seed pricing and productivity lift margins; sales fall 1% and the company raises its 2026 outlook.

Zacks
Corteva, Inc. Q2 2026 Earnings Call Summary

Moby summary of Corteva, Inc.'s Q2 2026 earnings call

Moby
Corteva, Inc. (CTVA) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Corteva, Inc. (CTVA) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks
Corteva, Inc. (CTVA) Q2 Earnings Beat Estimates

Corteva, Inc. (CTVA) delivered earnings and revenue surprises of +2.68% and -3.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Is CTVA Stock Worth Buying After a Powerful Rally and Earnings Beat?

Corteva's earnings beat, rising estimates and innovation pipeline support momentum, but premium valuation and separation costs raise execution risk.

Zacks
Why Corteva's Seed and Crop Protection Engines Matter to Investors

CTVA's Seed pricing, Crop Protection volumes and cost savings support growth ahead of its planned fourth-quarter 2026 separation.

Zacks
How Corteva's Innovation Pipeline Could Shape Its Next Growth Cycle

CTVA's $2 billion crop-protection pipeline, royalty gains and 2026 split could sharpen its technology-led growth story.

Zacks
Bunge's Q2 Earnings Miss Estimates, Sales Surge Y/Y on Higher Volumes

BG lifts its 2026 earnings outlook after Q2 sales nearly doubled and adjusted EPS jumped, as stronger soybean and softseed results fuel growth.

Zacks
Scotts Miracle-Gro (SMG) Tops Q3 Earnings Estimates

Scotts (SMG) delivered earnings and revenue surprises of +11.46% and -0.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Archer Daniels Midland (ADM) Earnings Expected to Grow: Should You Buy?

ADM (ADM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks
Corteva, Inc. (CTVA) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Corteva, Inc. (CTVA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

Zacks
Are Consumer Staples Stocks Lagging Vita Coco Company (COCO) This Year?

Here is how Vita Coco Company, Inc. (COCO) and Corteva, Inc. (CTVA) have performed compared to their sector so far this year.

Zacks
How Much Are Pricing Gains Boosting Mission Produce's Results?

AVO's improving avocado pricing, broader sourcing and Calavo deal could lift margins as supply-demand conditions normalize.

Zacks
Corteva, Inc. (CTVA) Upgraded to Buy: Here's What You Should Know

Corteva, Inc. (CTVA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks
Corteva Set to Report Q2 Earnings: What Investors Should Expect

CTVA's Q2 earnings may rise as premium seed demand, new products and productivity gains help offset pricing and inflation pressures.

Zacks
Corteva (CTVA) Dividend Reaffirmed As Earnings Beat Hopes Keep Valuation In Focus

Dividend affirmation and earnings expectations set the tone Corteva (CTVA) has reaffirmed a common stock dividend of $0.18 per share, payable on September 15, 2026. This announcement comes as analysts highlight expectations for higher earnings and revenue in the upcoming June quarter report. See our latest analysis for Corteva. Corteva’s recent momentum has been strong, with a 12.22% 1 month share price return and a 31.02% year to date share price return. The 5 year total shareholder return...

Simply Wall St.
Corteva (CTVA) Stock Looks Like A Bargain On Cash Flow, Priced For Perfection On Earnings

Corteva stock has more than doubled over the past five years, yet its valuation signals are pulling in different directions, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a discount while market based multiples suggest the shares are on the rich side. Corteva has delivered a 116.8% return over the past five years, which puts extra focus on whether the current share price still reflects a reasonable entry point. Expectations that Corteva can keep converting its...

Simply Wall St.
Does Rising Confidence In a 2026 Earnings Beat Change The Bull Case For Corteva (CTVA)?

Corteva, Inc. recently drew increased analyst attention as expectations rose that its June 2026 quarter would exceed prior earnings forecasts on higher revenues. Analysts are highlighting Corteva’s history of topping consensus earnings estimates and a positive Earnings ESP, which together are fueling confidence ahead of its upcoming report. We’ll now examine how analysts’ growing confidence in a potential earnings beat could reshape key elements of Corteva’s longer-term investment...

Simply Wall St.
Corteva, Inc. (CTVA) Earnings Expected to Grow: Should You Buy?

Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks
Chemicals Companies Likely to Report In-Line Quarterly Results, Deutsche Bank Says

US chemicals companies are likely to report quarterly results in line with expectations, with the Mi

MMT Newswires
Will Corteva, Inc. (CTVA) Beat Estimates Again in Its Next Earnings Report?

Corteva, Inc. (CTVA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection

Download the Complete Report Here Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection CBUS is an asset-light precision-breeding platform that develops productivity traits for seed-company partners, rather than owning seed production, distribution or farmer relationships. RTDS and the Trait Machine process are designed to edit elite customer germplasm and […] The post Cibus Inc’s Precision-Breeding Platform and BioFragra

EExec Edge
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report

Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com [email protected] The post Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report appeared first on ExecEdge.

EExec Edge
Oppenheimer Picks Apple, Amazon, Alphabet as Top Stock Buys

Oppenheimer Unveils Top Buy and Sell Stocks Across Every Sector

GuruFocus.com
Is Profitability Improving Across Mission Produce's Segments?

AVO sees profitability improving as avocado pricing stabilizes, Peru contributions rise and Calavo synergies begin to take hold.

Zacks
Zacks
The Wall Street Journal
Investing.com
MMT Newswires
Barchart
Zacks
Zacks
Simply Wall St.
Simply Wall St.